中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
31期
140-142
,共3页
血必净%慢性肾衰竭%临床观察
血必淨%慢性腎衰竭%臨床觀察
혈필정%만성신쇠갈%림상관찰
Xuebijing%Chronic renal failure%Clinical observation
目的:探讨血必净对慢性肾衰竭的治疗效果。方法将随机选取的该院2009年5月-2014年11月门诊收治的80例慢性肾衰竭患者平均分为2组,其中对照组采用常规治疗,治疗组在对照组基础上加用血必净静点,疗程14 d,观察治疗前后Bun及Scr变化情况。结果治疗组总有效率明显优于对照组(P<0.05),与治疗前相比,治疗组治疗后CCr明显上升(P<0.01),治疗前两组SCr无显著差异,治疗后。治疗组为(265.71±38.15)umol/L、对照组为(354.94±58.65)umol/L,差异具有统计学意义(P<0.01);治疗前两组BUN无显著差异,治疗后,治疗组为(16.65±3.88)umol/L,对照组为(23.45±6.28)umol/L,差异具有统计学意义(P<0.01)。结论血必净结合西医治疗治疗慢性肾衰竭,疗效显著。
目的:探討血必淨對慢性腎衰竭的治療效果。方法將隨機選取的該院2009年5月-2014年11月門診收治的80例慢性腎衰竭患者平均分為2組,其中對照組採用常規治療,治療組在對照組基礎上加用血必淨靜點,療程14 d,觀察治療前後Bun及Scr變化情況。結果治療組總有效率明顯優于對照組(P<0.05),與治療前相比,治療組治療後CCr明顯上升(P<0.01),治療前兩組SCr無顯著差異,治療後。治療組為(265.71±38.15)umol/L、對照組為(354.94±58.65)umol/L,差異具有統計學意義(P<0.01);治療前兩組BUN無顯著差異,治療後,治療組為(16.65±3.88)umol/L,對照組為(23.45±6.28)umol/L,差異具有統計學意義(P<0.01)。結論血必淨結閤西醫治療治療慢性腎衰竭,療效顯著。
목적:탐토혈필정대만성신쇠갈적치료효과。방법장수궤선취적해원2009년5월-2014년11월문진수치적80례만성신쇠갈환자평균분위2조,기중대조조채용상규치료,치료조재대조조기출상가용혈필정정점,료정14 d,관찰치료전후Bun급Scr변화정황。결과치료조총유효솔명현우우대조조(P<0.05),여치료전상비,치료조치료후CCr명현상승(P<0.01),치료전량조SCr무현저차이,치료후。치료조위(265.71±38.15)umol/L、대조조위(354.94±58.65)umol/L,차이구유통계학의의(P<0.01);치료전량조BUN무현저차이,치료후,치료조위(16.65±3.88)umol/L,대조조위(23.45±6.28)umol/L,차이구유통계학의의(P<0.01)。결론혈필정결합서의치료치료만성신쇠갈,료효현저。
Objective To investigate the therapeutic effect of xuebijing injection in treating chronic renal failure. Methods 80 patients admitted to outpatient department in our hospital between May 2009 and November 2014 were evenly divided into two groups. The control group was treated with conventional therapy, while the treatment group was given Xuebijing in-travenously additionally on the basis of conventional therapy for 14 d as one course. The changes of BUN and Scr before and after treatment were observed. Results The total effective rate of the treatment group was significantly superior to that of the control group, P<0.05; the CCr increased obviously in the treatment group after treatment compared with that before, P<0.01. No statistically significant difference can be found in SCr between the two groups before treatment, but after treat-ment, the SCr was(265.71±38.15)umol/L in the treatment group and (354.94±58.65)umol/L in the control group, and there was statistically significant difference between them, P<0.01; no statistically significant difference can be found in BUN be-tween the two groups before treatment, but after treatment, the BUN was (16.65±3.88)umol/L in the treatment group and(23.45±6.28)umol/L in the control group, and there was statistically significant difference between them, P<0.01. Conclusion Xuebijing injection combined with western medicine in the treatment of chronic renal failure has remarkable curative effect.